PUT - SPRINTER OPEN END - MERCK & CO. Share Price

Certificat

DE000VD22SN4

Market Closed - Bid/Ask 11:25:41 15/05/2024 pm IST After market 12:50:10 am
2.16 EUR -11.84% Intraday chart for PUT - SPRINTER OPEN END - MERCK & CO. 2.175 +0.69%
Current month-7.30%
1 month-18.49%
Date Price Change
15/24/15 2.16 -11.84%
14/24/14 2.45 +0.82%
13/24/13 2.43 +7.05%
10/24/10 2.27 -0.87%
09/24/09 2.29 -2.55%

Real-time Boerse Frankfurt Warrants

Last update May 15, 2024 at 11:25 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying MERCK & CO., INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VD22SN
ISINDE000VD22SN4
Date issued 28/03/2024
Strike 154.3 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.09
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2.79
Lowest since issue 2.08
Spread 0.01
Spread %0.46%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128.7 USD
Average target price
141.6 USD
Spread / Average Target
+10.09%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW